For clinical researchers, the most valuable insights are often trapped in unstructured formats. The daily deluge of doctor's notes, discharge summaries, and progress reports holds real-world patient data. Unlocking it requires painstaking manual de-identification and coding.
Amorphous AI, an Oxford startup, bets a multi-agent AI system called Striata can automate this. It transforms raw clinical text into analysis-ready data in real time [SNOMED International, post-2024].
The core bet: standardize messy data at ingestion for a "data team of one" [Amorphous AI, Unknown]. Striata ingests text, de-identifies for privacy, and maps to SNOMED CT, LOINC, and ICD-10.
Output fuels studies, real-world evidence, and operational decisions on cost and efficiency [Amorphous AI, Unknown]. This places Amorphous AI in a crowded healthtech market with established players and funded startups.
Early validation includes a SNOMED International case study on Striata [SNOMED International, post-2024]. The path to adoption requires proven accuracy, hospital IT integration, and regulatory validation.
The company is formative and pre-revenue, with UK and Latvia entities registered and a $3.3M pre-seed reported [LinkedIn, Unknown]. Future milestones to watch include the first hospital deployment and validation studies on Striata.